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Appendix 1: Plasmid Maps 
1.1 Plasmids for targeting  
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pENTR2B DUAL SELECTION VECTOR
3755 bp
Kan(R)
ccdB
Cm(R)
pUC origin rrnB T2 transcription terminator
rrnB T1 transcription terminator
attL2
attL1
3755 bp 
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pENTR2B DUAL SELECTION VECTOR
3755 bp
Kan(R)
ccdB
Cm(R)
pUC origin rrnB T2 transcription terminator
rrnB T1 transcription terminator
attL2
attL1
pENTR2B Ftl/Fth 
3572 bp 
Gateway Targeting Vector Ftl/Fth 
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1.2 Plasmids for random integration 
 
 
 
 
 
 
 
pIRES2 EGFP CAG
6407 bp
CAG Enhancer
SV40 Enhancer
IRES
EGFPF1 ori
pBR322 ori
NeoR/KanR
SV40 Promoter
TKPA Term
EcoRI (1729)
pEC  
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pIRES2 EGFP CAG Ftlh
7572 bp
CAG Enhancer
SV40 Enhancer
IRESEGFP
F1 ori
pBR322 ori
Ftlh
NeoR/KanR
SV40 Promoter
TKPA Term
EcoRI (1729)
HindIII (2161)
HindIII (3156)
pEC – Ftl/Fth 
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1.3 Cre Plasmid 
 
Appendix 2: Preparation of the LIF plasmid 
The LIF expression vector (Ampicilin resistant) was previously donated by Vladamir 
Buchman. It was transformed into TOP 10 competent cells using heat shock at 42°C 
for 1 min, then transfer to ice for 2 min and purified by Endofree Maxi prep (Qiagen) 
for further details see Chapter 2. The LIF was transfected using lipofection into COS 
cells. COS cells were maintained in DMEM supplemented with 10% foetal calf serum, 
1% Pen/Strep and L-Glutamine with media changes every two to three days and 
passaging at 80% confluence using Trypsin-EDTA. At 60-70% confluence cells were 
transfectred and a few hours prior to transfection, media was changed for that 
containing no Pen/Strep.  
Using one 6cm dish 8μg of DNA was added into 50μl Opti-MEM.  Lipofectamine was 
mixed before use. 20μl Lipofectamine was added into 50μl Opti-MEM and incubated 
for 5mins at room temperature. The DNA containing Opti-MEM was then combined 
with the Lipofectamine, mixed gently and incubated at room temperature for 20mins 
(solution may appear cloudy). This was added to the cells with 2 mls of OptiMEM 
and incubated at 37°C for 24 hours.  
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After 24 hours the transfection mix was discarded and 10ml ES cell medium without 
LIF or Pen/Strep was added and left over night at 37°C. The media was collected 
into 50ml tube the next day (kept at 4°C). A further 10ml ES cell medium without LIF 
or Pen/Strep was added to the cells and left at 37°C overnight. Once again this 
media was collected and pooled with the previous batch of media and filter sterilised. 
The media was stored in aliquots at -20°C. 
The LIF conditioned media was tested at various concentrations in clonally plated 
mouse ES cell cultures, in 6-well plates and compared against ‘No LIF’ and ‘old LIF’, 
to determine the optimal concentration of ‘new LIF’ to use in ES cell medium. 
Leishman’s stain was used to determine the optimal concentration of LIF. 
Appendix 3: Recipes 
Molecular Antibiotic Concentrations 
Ampicilin: 100 µg/ml and for LIF production 150µg/ml 
Kanamycin: 30-50 µg/ml 
Chloramphenicol: 15-30 µg/ml 
Tissue Culture Antibiotic Concentrations 
G418 (Geneticin) 200µg/ml (Sigma) 
Puromycin 1ng/ml (Sigma) 
Southern Blot Specific Solutions 
20xSSC 
175.3g NaCl 
88.2g Na citrate 
800ml H20 
pH 7.0  
Adjust to 1 litre with H20 
Autoclave sterilize 
Western Blot Specific Solutions 
Lysis Buffer      
1ml RIPA Buffer (Sigma), Complete Mini 1x solution (Roche)     
Protein assay. 
Want 20-40ug/lane (max. vol 30µl) 
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Western blotting buffers 
10x running buffer    
0.25M Tris base, 1.92M glycine, 0.1% SDS pH 8.3  
1x TBS   (Tris buffered saline) 
10mM Tris, 150mM NaCl, pH 7.6 
Transfer buffer  
0.25M Tris base, 1.92M glycine, 20% methanol   
Sample loading buffer  
2% SDS, 10% glycerol, 60mM Tris base pH 6.8, 0.005% Bromophenol blue, 500mM 
DTT  
Resolving gel  
12% Acrylamide (Sigma-Aldrich), 0.37M Tris, 0.1% SDS, 0.1% Ammonium 
persulphate (APS), 0.06% tetramethylethylenediamine (TEMED) (Sigma- Aldrich). 
Stacking Gel  
5% Acrylamide (Sigma-Aldrich), 0.125M Tris, 0.1% SDS, 0.05% APS, 0.5% TEMED 
(Sigma- Aldrich).  
Ponceau S 
0.1% in 5% acetic acid 
Wash buffer 
1x TBS, 0.1% Tween 20 (Sigma) 
Antibody blocking solution 
1% skimmed milk powder (Marvel, UK) in 1x TBS, 0.1% Tween 20 (Sigma)  
Ponceau S 
0.1% in 5% acetic acid 
Antibody blocking solution 
1% marvel in TBS/Tween + 100l sodium azide (1M) per 20ml 
Rainbow marker (GE Healthcare) 
10l / lane 
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Gel running 
Either 200V for 30min (100V for 1h) or 100V stacking gel (15min) 150V resolving gel 
(1h) 
Quinolinic Acid 
QA was dissolved in 0.1M phosphate buffer to make a 90mM solution. The working 
concentration was 45nmol. 
6-Hydroxydopamine 
One gram of 6-OHDA (hydrobromide salt) (Sigma), was dissolved in 0.8ml of sterile 
saline, giving a 30mM solution of 6-OHDA with 0.03% ascorbic acid as a stabilizer 
and a concentration of 5.14 mg/ml of the free base. The dissolved neurotoxin was 
frozen as 100µl aliquots for future use and when required they were thawed quickly 
and stored on ice during surgery for a maximum of two hours after which they were 
discarded. 
Fixative (4% paraformaldehyde) 
40g PFA 
1L Prewash Buffer 
Heat with addition of NaOH to dissolve  
pH 7.3 
 
